UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day

Journal of clinical pharmacy and therapeutics, 2013-08, Vol.38 (4), p.314-320

2013

Volltextzugriff (PDF)

Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model

Human reproduction (Oxford), 2011-06, Vol.26 (6), p.1362-1370

2011

Volltextzugriff (PDF)

Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate

Journal of clinical pharmacy and therapeutics, 2013-12, Vol.38 (6), p.512-517

2013

Volltextzugriff (PDF)

AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

British journal of pharmacology, 2008-01, Vol.153 (1), p.157-163

2008

Volltextzugriff (PDF)

AS601245, a c‐Jun NH 2 ‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

British journal of pharmacology, 2009-01, Vol.153 (1), p.157-163

2009

Volltextzugriff (PDF)

Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase

Journal of medicinal chemistry, 2004-12, Vol.47 (27), p.6921-6934

2004

Volltextzugriff (PDF)

Inhibition of Steroid Sulfatase Decreases Endometriosis in an In Vivo Murine Model

Obstetrical & gynecological survey, 2011-10, Vol.66 (10), p.620-622

2011

Volltextzugriff (PDF)

O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials

Human reproduction (Oxford), 2021-08, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Design and synthesis of new potential photoaffinity labels for mammalian squalene epoxidase

Bioorganic & medicinal chemistry letters, 1997-05, Vol.7 (9), p.1153-1156

1997

Volltextzugriff (PDF)

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells : A new type of potent squalene epoxidase inhibitors

Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (11), p.1337-1342

1998

Volltextzugriff (PDF)

(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3207-3216

1995

Volltextzugriff (PDF)

Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties

Bioorganic & medicinal chemistry letters, 1996-03, Vol.6 (5), p.533-538

1996

Volltextzugriff (PDF)

Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats

British journal of pharmacology, 2004-07, Vol.142 (6), p.953-960

2004

Volltextzugriff (PDF)

Design and Synthesis of the First Generation of Novel Potent, Selective, and in Vivo Active (Benzothiazol-2-yl)acetonitrile Inhibitors of the c-Jun N-Terminal Kinase

Journal of medicinal chemistry, 2005-07, Vol.48 (14), p.4596-4607

2005

Volltextzugriff (PDF)

Structure of dimethyl (±)-1,2,3,4,4aα,4b,9,10-octahydro-6,7-bis(trimethylsilyl)-2β,10aβ-ethanophenanthrene-12,12-dicarboxylate

Acta crystallographica. Section C, Crystal structure communications, 1990-07, Vol.46 (7), p.1271-1273

1990

Volltextzugriff (PDF)

AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties

The Journal of pharmacology and experimental therapeutics, 2004-07, Vol.310 (1), p.25

2004

Volltextzugriff (PDF)

Control of death receptor and mitochondrial‐dependent apoptosis by c‐Jun N‐terminal kinase in hippocampal CA1 neurones following global transient ischaemia

Journal of neurochemistry, 2005-03, Vol.92 (5), p.1054-1060

2005

Volltextzugriff (PDF)

LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

HUMAN REPRODUCTION, 2022, Vol.37, p.I111

2022

Volltextzugriff (PDF)

Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials

HUMAN REPRODUCTION, 2021, Vol.36, p.59

2021

Volltextzugriff (PDF)

Stereoselective access to the basic skeleton of tetracyclic diterpenes via a sequence of consecutive [3 + 2], [2 + 2 + 2], and [4 + 2] cycloaddition reactions

Journal of organic chemistry, 1993-07, Vol.58 (16), p.4298-4305

1993

Volltextzugriff (PDF)

AS601245, a c-Jun NH sub(2)-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

British journal of pharmacology, 2008-01, Vol.153 (1), p.157-163

2008

Volltextzugriff (PDF)

TRANSLATIONAL RESEARCH

Human reproduction (Oxford), 2012-07, Vol.27 (suppl_2), p.ii344-ii348

2012

Volltextzugriff (PDF)

Synthetic approach to aphidicolan and stemodan basic skeletons using a “Tandem Principle” [2+2+2] and [4+2] cycloaddition reactions

Tetrahedron letters, 1994-01, Vol.35 (3), p.417-420

1994

Volltextzugriff (PDF)

A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells

Assay and drug development technologies, 2006-08, Vol.4 (4), p.451

2006

Volltextzugriff (PDF)

ChemInform Abstract: Design and Synthesis of New Potential Photoaffinity Labels for Mammalian Squalene Epoxidase

ChemInform, 1997-09, Vol.28 (40), p.no-no

1997

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(42)
Tagungsberichte
(3)

Sprache

Englisch
(45)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(13)
Biological And Medical Sciences
(11)
Animals
(10)
Chemistry
(10)
Medical Sciences
(10)
Pharmacology & Pharmacy
(10)
Pharmacology. Drug Treatments
(9)
Physical Sciences
(8)
Chemistry, Organic
(7)
Humans
(7)
Exact Sciences And Technology
(6)
Acetonitriles - Pharmacology
(5)
Chemistry, Medicinal
(5)
Jnk Mitogen-Activated Protein Kinases - Antagonists & Inhibitors
(5)
Rats
(5)
Benzothiazoles
(4)
Male
(4)
Medicinal Chemistry
(4)
Organic Chemistry
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day

Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model

Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate

AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

AS601245, a c‐Jun NH 2 ‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase

Inhibition of Steroid Sulfatase Decreases Endometriosis in an In Vivo Murine Model

O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials

Design and synthesis of new potential photoaffinity labels for mammalian squalene epoxidase

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells : A new type of potent squalene epoxidase inhibitors

(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors

Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties

Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats

Design and Synthesis of the First Generation of Novel Potent, Selective, and in Vivo Active (Benzothiazol-2-yl)acetonitrile Inhibitors of the c-Jun N-Terminal Kinase

Structure of dimethyl (±)-1,2,3,4,4aα,4b,9,10-octahydro-6,7-bis(trimethylsilyl)-2β,10aβ-ethanophenanthrene-12,12-dicarboxylate

AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties

Control of death receptor and mitochondrial‐dependent apoptosis by c‐Jun N‐terminal kinase in hippocampal CA1 neurones following global transient ischaemia

LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials

Stereoselective access to the basic skeleton of tetracyclic diterpenes via a sequence of consecutive [3 + 2], [2 + 2 + 2], and [4 + 2] cycloaddition reactions

AS601245, a c-Jun NH sub(2)-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

TRANSLATIONAL RESEARCH

Synthetic approach to aphidicolan and stemodan basic skeletons using a “Tandem Principle” [2+2+2] and [4+2] cycloaddition reactions

A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells

ChemInform Abstract: Design and Synthesis of New Potential Photoaffinity Labels for Mammalian Squalene Epoxidase

Suchergebnisse filtern